Friday, November 20, 2026

Subscribe

NewsEdition DR CongoDR Congo

DR Congo targets Kisangani in Ebola vaccination drive

DR Congo has launched an Ebola vaccination campaign in Kisangani, prioritising health workers and contacts of patients. The response targets six affected provinces and aims to strengthen surveillance in the east of the country.

Medical logistics at a wholesale market in Kisangani, with workers preparing vaccine boxes and documents.

A response that must move quickly, far from major centres

In Kisangani, Ebola vaccination is not just a public health measure. It is also a test of speed for a health system that must protect those providing care, trace contacts and contain the spread of the virus in a country where distances, river routes and daily movements make everything more difficult. In Tshopo, the first people targeted are therefore those who make most sense: health workers and people exposed through contact with patients.

The Democratic Republic of the Congo is no stranger to outbreaks. Over the years, the country has built recognised expertise in managing Ebola, but that experience confronts a simple reality: each new epidemic moves, shifts to another province and forces authorities to start again with surveillance systems that can be fragile. In the east and north-east, the proximity of Ituri, Haut-Uélé and Tshopo shows how the response extends beyond a single city.

What the available figures show

The campaign was launched on Friday 28 August 2026 in Kisangani, the capital of Tshopo, according to local media that covered the event. The first doses were intended for frontline personnel. Congolese health authorities also said that the province already had 17 confirmed cases at the time of the launch, while surveillance had been extended to several health zones.

Vaccine stocks are another important indicator. The World Health Organization confirmed that an initial immediate shipment of 70,000 doses of Ervebo had been approved for the DRC, with 50,000 doses earmarked for health workers and frontline responders, and 20,000 doses set aside for a clinical trial linked to the Bundibugyo virus. The WHO also notes that the vaccine is approved for outbreaks caused by the species known as Zaire ebolavirus, which helps explain the choice of vaccine in this response.

On the ground, the challenge is not simply to have doses available. They must also be transported, the cold chain maintained and health workers persuaded to take them, in a context where frontline teams are often exposed, sometimes exhausted and not always well paid. In recent weeks, tensions over payments to service providers have even been reported in Kisangani, a reminder that logistics and trust matter as much as the vaccine itself.

The stakes for Tshopo, and then the region

Targeted vaccination reflects a standard ring vaccination strategy, tailored to the most exposed health workers and direct contacts. It protects health facilities, limits chains of transmission and prevents the infection from spreading to new hotspots. But it does not replace community surveillance or rapid testing. In Kisangani, the authorities have also strengthened control measures and opened discussions on new treatment centres and improved local diagnostics.

River and road transport add another layer of complexity. A case linked to a boat that left Kisangani has already required contact-tracing work, showing that the disease can follow routes used for trade and everyday travel. In the same vein, local voices have reported that health checks remain inadequate on routes linking Ituri to Tshopo. For a province that serves as a crossroads, the fight against Ebola is therefore a matter of public health, but also of mobility and territorial coordination.

The Congolese government has also launched the “Congo River Ebola-Free” initiative to improve surveillance along the corridor between Kisangani and Kinshasa. The message is clear: what is happening in Tshopo can quickly affect the whole country, through trade, passengers, markets and entry points to the capital, Kinshasa. This domestic dimension is linked to the regional picture, as the DRC shares borders and flows of people with several Central and East African states.

A Congolese alert with continental reach

Across Africa, this campaign is a reminder of an often-underestimated truth: the response to Ebola depends as much on laboratories and vaccines as on basic health systems, the flow of information and governments’ ability to act early. Africa CDC and the WHO have welcomed the allocation of doses to the DRC, proof that continental coordination remains essential in the face of a disease that quickly crosses administrative boundaries.

But the current situation also highlights an important limitation. The WHO has said that the current episode is linked to the Bundibugyo virus, while Ervebo is recommended primarily against the Zaire ebolavirus strain. In other words, vaccination first protects the teams most exposed, but it does not, on its own, resolve the scientific and operational questions raised by this outbreak. This is precisely where the DRC is playing the role of an African testing ground for the response, balancing urgency, adaptation and the production of data useful to the continent.

Automatic translation. Original French version

News quiz

Edition DR CongoDR Congo: the news quiz for 14–15 November

5 questions